Mayo Clinic Health Manager
Get free personalized health guidance for you and your family.
Get Started
close window
Housecall Archives
About our e-newsletters
- Free e-newsletters
- Mayo Clinic expertise
- We do not share your e-mail address
Housecall, our weekly general-interest e-newsletter, keeps you up to date on a wide variety of health topics with timely, reliable, practical information, recipes, blogs, questions and answers with Mayo Clinic experts and more. Our biweekly topic-specific e-newsletters also include blogs, questions and answers with Mayo Clinic experts, and other useful information that will help you manage your health.
Housecall Archives
close window
Mayo Clinic Housecall
Stay up to date on the latest health information.
What you get
- Free weekly e-newsletter
- Mayo Clinic expertise
- Recipes, tools and other helpful information
- We do not share your e-mail address
Selected references
- Ackermann RT, Mulrow CD, Ramirez G, et al. Garlic shows promise for improving some cardiovascular risk factors. Arch Intern Med 2001; 161(6):813-824.
- Andrianova IV, Fomchenkov IV, Orekhov AN. [Hypertensive effect of long-acting garlic tablets allicor (a double-blind placebo-controlled trial)]. Ter Arkh 2002; 74(3):76-78.
- Ashraf R, Aamir K, Shaikh AR, et al. Effects of garlic on dyslipidemia in patients with type 2 diabetes mellitus. J Ayub Med Coll Abbottabad. 2005 Jul-Sep;17(3):60-4.
- Bordia A. [Garlic and coronary heart disease. Results of a 3-year treatment with garlic extract on the reinfarction and mortality rate]. Deutsche Apotheker Zeitung 1989;129(28 suppl 15):16-17.
- Fleischauer AT, Arab L. Garlic and cancer: a critical review of the epidemiologic literature. J Nutr 2001;131(3s):1032S-1040S.
- Hassan HT. Ajoene (natural garlic compound): a new anti-leukaemia agent for AML therapy. Leuk Res 2004;28(7):667-671.
- Josling P. Preventing the common cold with a garlic supplement: a double-blind, placebo-controlled survey. Adv Ther 2001;18(4):189-193.
- Kwon SK, Moon A. Synthesis of 3-alkylthio-6-allylthiopyridazine derivatives and their antihepatocarcinoma activity. Arch Pharm Res 2005;28(4):391-394.
- McCrindle BW, Helden E, Conner WT. Alternative medicine -- a randomized double blind placebo-controlled clinical trial of garlic in hypercholesterolemic children [white diamond suit] 661. Pediatric Res 1998;43(4 suppl 2):115.
- McNulty CA, Wilson MP, Havinga W, et al. A pilot study to determine the effectiveness of garlic oil capsules in the treatment of dyspeptic patients with Helicobacter pylori. Helicobacter 2001;6(3):249-253.
- Sabitha P, Adhikari PM, Shenoy SM, et al. Efficacy of garlic paste in oral candidiasis. Trop Doct 2005;35(2):99-100.
- Siegel G. Long-term effect of garlic in preventing arteriosclerosis - results of two controlled clinical trials. Eur Phytojournal 2001;Symposium posters(1):1.
- Sobenin IA, Prianishnikov VV, Kunnova LM, et al. [Reduction of cardiovascular risk in primary prophylaxy of coronary heart disease]. Klin Med (Mosk) 2005;83(4):52-55.
- Stevinson C, Pittler MH, Ernst E. Garlic for treating hypercholesterolemia. A meta-analysis of randomized clinical trials. Ann Intern Med 2000;133(6):420-429.
- Turner B, Molgaard C, Marckmann P. Effect of garlic (Allium sativum) powder tablets on serum lipids, blood pressure and arterial stiffness in normo-lipidaemic volunteers: a randomised, double-blind, placebo-controlled trial. Br J Nutr 2004;92(4):701-706.
NS_patient-garlic
Portions of this document last updated:Sept. 1, 2009
THIS EVIDENCE-BASED MONOGRAPH WAS PREPARED BY
THE NATURAL STANDARD RESEARCH COLLABORATION
(www.naturalstandard.com)
THE NATURAL STANDARD RESEARCH COLLABORATION
(www.naturalstandard.com)
